Overview
- Coverage tied to World Multiple Sclerosis Day on May 30 renewed calls for awareness and stressed that early diagnosis and rapid treatment can stabilize disease and reduce permanent neurological damage.
- Health agencies estimate more than 2.8 million people live with MS worldwide and about 40,000 people in Brazil, with the condition most common in adults aged 20–50 and roughly twice as frequent in women.
- Common warning signs include persistent fatigue, visual changes, numbness or tingling, muscle weakness and balance problems, and doctors say these intermittent symptoms often lead to months or years of delayed diagnosis.
- Brazil’s PCDT and the SUS provide a path to free high-cost MS drugs through specialist evaluation, an LME form and exams such as MRI and cerebrospinal fluid analysis, but patients still face bottlenecks accessing neurologists and timely testing.
- Clinicians and patient groups urge multidisciplinary care, lifestyle measures like quitting smoking and maintaining vitamin D, and continued public education and policy attention to reduce diagnostic delays and improve long-term outcomes.